5 Takeaways from FDAs Draft Guidance

March 21, 2016

Read the full article (MDDI DeviceTalk) >

Data are becoming an increasingly integral component of medical technologies, including medical devices. However, the sensitive nature of healthcare data increases the risk that device companies and their partners will be targets of cyberattacks and heightens the consequences of a breach.

The FDA’s guidance doesn't cover all regulatory risks related to cyberattacks and provides no safe harbor for device makers.


The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.


Richard Martinez

Back to Top